|
|
|
Insider
Information: |
Adams Brian |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
451,836 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,195,670 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
451,836 |
|
|
Total
Value |
$2,195,670 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
22
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
20
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-23.6%
|
-679.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
General Counsel and Se... |
2018-02-15 |
126,069 |
|
0 |
Premium* |
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
325,767 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-06-27 |
4 |
S |
$12.12 |
$3,563 |
D/D |
(294) |
133,515 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-04-28 |
4/A |
S |
$11.16 |
$21,606 |
D/D |
(1,936) |
133,809 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-10-30 |
4 |
S |
$6.03 |
$8,472 |
D/D |
(1,405) |
134,015 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-04-28 |
4 |
S |
$11.16 |
$9,631 |
D/D |
(863) |
134,882 |
0 |
% |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-10-05 |
4 |
S |
$7.19 |
$4,530 |
D/D |
(630) |
135,420 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-03-27 |
4 |
S |
$15.36 |
$5,330 |
D/D |
(347) |
135,745 |
0 |
% |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-07-31 |
4 |
S |
$7.14 |
$10,317 |
D/D |
(1,445) |
136,050 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-01-30 |
4 |
S |
$21.56 |
$18,628 |
D/D |
(864) |
136,092 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
85,425 |
136,956 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-07-05 |
4 |
S |
$7.67 |
$4,916 |
D/D |
(641) |
137,495 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
138,136 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-04-17 |
4 |
S |
$5.75 |
$6,268 |
D/D |
(1,090) |
139,577 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-04-05 |
4 |
S |
$5.80 |
$3,724 |
D/D |
(642) |
140,667 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
141,309 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2024-04-29 |
4 |
S |
$6.38 |
$10,355 |
D/D |
(1,623) |
325,767 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2024-03-27 |
4 |
S |
$7.70 |
$2,680 |
D/D |
(348) |
327,390 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2024-01-29 |
4 |
S |
$9.64 |
$18,596 |
D/D |
(1,929) |
327,738 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
329,667 |
0 |
- |
|
68 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|